News & Articles
Announcements, discoveries, and leadership in the field.
-
Flagship startup Senda Biosciences raises $123 million for mRNA medicinesThe Boston Globe
-
Two years post-merger, Flagship’s Senda refines pipeline and replenishes the bankEndpoints News
-
Investors Senda message with $123M to back mystery pipeline from Flagship's reinvented biotechFierce Biotech
-
Senda Biosciences Announces Close of $123 Million Series C FinancingSenda Biosciences
-
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform BiologySenda Biosciences
-
Fierce Biotech Names Senda Biosciences a 2021 "Fierce 15" CompanyFierce Biotech
-
Senda Biosciences Strengthens Leadership Team with Key Management HiresSenda Biosciences
-
Flagship's platform tech firm Senda raises $98M to explore intersystems biologyBioWorld
-
Senda Biosciences Announces Closing of $98 Million Series B FinancingSenda Biosciences
-
Senda Biosciences to virtually present at the Chardan 3rd Annual Microbiome Medicines SummitSenda Biosciences